All lobbying filings

TIBER CREEK GROUP

Lobbying for VERTEX PHARMACEUTICALS · Global biotechnology company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $60,000.00 income · posted Oct 19, 2025

Official filing document

Bills named in this filing 4

HR 1227
Alternatives to PAIN Act
S 475
Alternatives to PAIN Act
HR 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…
S 2296
National Defense Authorization Act for Fiscal Year 2026

Lobbying activity 2

Health Issues

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act.

Defense

Issues related to opioid alternatives; Issues related to H.R. 3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; Issues related to S. 2296 - National Defense Authorization Act for Fiscal Year 2026.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.